lmwh

It is found that LMWH can play an important role in the pathological process of vascular endothelial hyperplasia after balloon injury restenosis , which provides a new theory and method for the prevention and treatment of restenosis .

表明低分子肝素在预防血管内膜损伤后内皮增生所致再狭窄的病理过程中发挥重要作用，尤其应损伤早期用药。这将为临床防治术后再狭窄提供了一种新的理论和方法。

Preparation of LMWH and the relationship between its structure and bioactivity

低分子肝素的制备方法及其结构与生物活性的关系

One of the most important aspect in LMWH quality standard is the molecular weight .

分子量及分布是LMWH质量标准的的一个重要指标。

The Change of Cell Factors and Effect of LMWH on Nephrotic Syndrome Model of Rat

阿霉素肾病模型大鼠细胞因子的变化及低分子肝素对其影响

The clinical value of LMWH in the treatment of pulmonary heart disease of the acute stage

低分子肝素治疗肺心病急性发作期30例临床价值

CR test can be used to monitor the anticoagulant effect of LMWH .

CR值有可能成为LMWH抗凝活性的床旁检测指标。

CONCLUSION : LMWH in the treatment of acute ischemic stroke is effective and safe .

结论：低分子肝素治疗急性缺血性中风是安全有效的。

International Circulation : Which LMWH would you normally choose to use in ACS patients ?

《国际循环》：对ACS患者通常你会选择使用哪种低分子量肝素？

Objective To explore thrombolysis action of low molecular weight heparin ( LMWH ) .

目的探讨低分子肝素（LMWH）的溶栓作用。

Objective To observe the curative effects of LMWH on the treatment of TIA .

目的观察低分子肝素治疗短暂性脑缺血发作（TIA）的疗效。

CONCLUSION LMWH can be used to modify SOD and improve the properties of the enzyme .

结论用LMWH可成功修饰SOD，并改进SOD性能。

Conclusion LMWH can inhibit the tumor angiogenesis in vitro .

结论LMWH具有体外抑制肿瘤血管新生的作用。

The study provided the theoretical foundation and experiment evidence for preparing oral drug delivery system of LMWH .

本课题为进一步研制LMWH口服给药系统奠定了理论基础和实验依据。

Objective To study the effect of low molecular weight heparin ( LMWH ) on tumor angiogenesis .

目的探讨低分子量肝素（lowmolecularweightheparin，LMWH）对肿瘤血管新生的作用。

The hydrolytic kinetics of LMWH solution was studied at different pH and temperatures .

考察了低分子肝素溶液在不同pH、不同温度下的水解动力学。

Effects of LMWH and heparin by two administration routes on thrombosis and blood coagulation

两种给药途径对低分子量肝素和肝素抗栓与抗凝作用的动物实验研究

Conclusions LMWH was an ideal anticoagulant for patients of maintaining hemodialysis .

透析器及血路管复用容易。结论LMWH是维持性血液透析较为理想的抗凝剂。

Preparation and Structure-Activity Differences of Low Molecular Weight Heparins ( LMWH )

低分子量肝素的制备及其结构与活性差异（英文）

Anticoagulation therapy mainly includes application of UFH and LMWH .

抗凝治疗主要包括应用UFH和LMWH。

Conclusion : LMWH may be used as an early intervention method routinely in the treatment of ACS patients .

结论：低分子肝素可作为常规用于急性冠脉综合征患者的早期干预治疗。

Study of toxicity of combined application of 5-FU and LMWH in the anterior chamber of rabbits

5-氟尿嘧啶联合低分子肝素兔前房灌注的毒性研究

Conclusion VEGF-ASODN combined with LMWH can enhance anti-tumor effect .

结论VEGF-ASODN和LMWH联合有协同抗肿瘤作用；

LMWH therapy for SAP is safe and can not lead to bleeding tendency .

LMWH治疗SAP不会引起出血倾向。

Methods : Select 31 patients who were given LMWH after having coronary inserted with a stent .

方法：选择冠状动脉支架植入术后应用低分子肝素治疗的患者31例，随机分为两组，实验组18例，对照组13例。

CONCLUSION : LMWH exhibits thrombolytic activity by activating the fibrinolytic system in vivo .

结论：LMWH通过激活体内纤溶系统发挥溶栓作用。

Conclusions LMWH combined with routine therapies in treating patients with severe preeclampsia is helpful .

结论低分子肝素结合常规疗法治疗重度子癎前期患者，可显著改善治疗效果。

OBJECTIVE : To investigate the gastrointestinal absorption of LMWH solution and emulsion in anesthetized rats .

目的：以血浆抗Xa活性及体内抗静脉血栓形成为指标，考察了低分子肝素（LMWH）溶液及乳剂在麻醉大鼠胃肠道的吸收情况。

Blood viscosity changes were studied on rabbits after oral LMWH , UFH capsules .

本文对家兔口服自制LMWH、UFH胶囊后血液粘度的改变进行了实验研究。

Methods : Patients were randomly divided into LMWH plus aspirin treatment group and aspirin con-trol group .

方法：病人被随机分成低分子肝素加阿斯匹林治疗组和阿斯匹林对照组。

The effect of LMWH and UFH were similar for long term hemodialysis patients . 3 .

长期血液透析老年患者使用低分子肝素和普通肝素的抗凝效果是相似的。